Sector
PharmaceuticalsOpen
₹16.2Prev. Close
₹16.25Turnover(Lac.)
₹0.03Day's High
₹16.2Day's Low
₹15.752 Week's High
₹27.8252 Week's Low
₹15.46Book Value
₹14.1Face Value
₹10Mkt Cap (₹ Cr.)
4.71P/E
0EPS
0Divi. Yield
029 Aug 2024
12:00 AM
AGM
Announcement Date: 29 Aug, 2024
5 Sep 2023
12:00 AM
BookCloser
4 Feb 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 3 | 3 | 3 | 3 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2.06 | 3.31 | 4.22 | 5.79 |
Net Worth | 5.06 | 6.31 | 7.22 | 8.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 34.97 | 49.61 | 55.78 | 60.54 |
yoy growth (%) | -29.5 | -11.05 | -7.86 | 29.14 |
Raw materials | -30.02 | -42.1 | -48.84 | -52.19 |
As % of sales | 85.84 | 84.85 | 87.56 | 86.19 |
Employee costs | -2.36 | -3.08 | -2.98 | -1.98 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.35 | 0.81 | 1.96 | 1.75 |
Depreciation | -0.03 | -0.03 | -0.03 | -0.03 |
Tax paid | -0.19 | -0.22 | -0.67 | -0.36 |
Working capital | -0.47 | 1.27 | 0.39 | 3.94 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -29.5 | -11.05 | -7.86 | 29.14 |
Op profit growth | -181.67 | -62.6 | 59.04 | -13.56 |
EBIT growth | -137.15 | -56.93 | 10.78 | 30.06 |
Net profit growth | -193.12 | -53.86 | -7.99 | 46.66 |
| Particulars (Rupees in Crores.) | Mar-2023 |
|---|---|
Gross Sales | 0.48 |
Excise Duty | 0 |
Net Sales | 0.48 |
Other Operating Income | 0 |
Other Income | 0.24 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,686.25 | 128.43 | 4,04,587.86 | 1,181.05 | 0.8 | 5,985.33 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 5,940.85 | 76.08 | 1,57,710.9 | 594 | 0.5 | 2,297 | 513.62 |
Cipla Ltd CIPLA | 1,512 | 26.24 | 1,22,115.23 | 1,438.15 | 0.86 | 4,134.87 | 360.72 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,238 | 60.07 | 1,09,583.71 | 485 | 0.86 | 2,330 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,497.8 | 53.29 | 1,03,053.87 | 416.38 | 0 | 2,396.57 | 334.17 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Director
Brij Raj Gupta
Company Sec. & Compli. Officer
Priyanka Sharma
Independent Director
Pooja Jha
Independent Director
Mayank Jain
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Brawn Biotech Ltd
Summary
Brawn Biotech Ltd was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985. Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010. Brawn , with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide. Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies. The Company is trading in Herbals, Ayurvedic and Critical Care range of Products along with other pharmaceutical products and distributing them in the overseas market, resulting in tremendous growth in sale and profits of the Company. Presently, the Company is also acting as consignee agent for the supplies to Government Hospitals and institutions.The Company is into Wholesale of Pharmaceutical and Medical Goods. Their Pharmaceutical Products cover all major product segments like Antibacterials, Cardiovasculars, Antidiabetics, Analgesics, Gastrointestinals, Antifungals, Skin Care, Antipsychotics, Antiasthmatics, Antacids, Antimalarials, and Nutriti
Read More
What is the Brawn Biotech Ltd share price today?
The Brawn Biotech Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹15.7 today.
What is the Market Cap of Brawn Biotech Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brawn Biotech Ltd is ₹4.71 Cr. as of 12 May ‘25
What is the PE and PB ratio of Brawn Biotech Ltd?
The PE and PB ratios of Brawn Biotech Ltd is 0 and 1.11 as of 12 May ‘25
What is the 52 Week High and Low of Brawn Biotech Ltd?
The 52-week high/low is the highest and lowest price at which a Brawn Biotech Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Brawn Biotech Ltd is ₹15.46 and ₹27.82 as of 12 May ‘25
What is the CAGR of Brawn Biotech Ltd?
Brawn Biotech Ltd's CAGR for 5 Years at -10.60%, 3 Years at -2.44%, 1 Year at -40.84%, 6 Month at -32.18%, 3 Month at -19.59% and 1 Month at -3.27%.
What is the shareholding pattern of Brawn Biotech Ltd?
The shareholding pattern of Brawn Biotech Ltd is as follows:
Promoters - 53.66 %
Institutions - 0.35 %
Public - 45.99 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
